The Thyroid

The thyroid gland is the “master controller” of metabolism.
Graves' Disease

Graves' Disease

SHARE

Graves’ disease is an autoimmune thyroid disease that leads to a generalised overactivity of the entire thyroid gland.1 It is an “autoimmune”, or “self-attacking self” disease. This means that proteins (antibodies) produced by our own white blood cells overstimulate the thyroid gland to produce too much thyroid hormone. The antibody which causes this is called TSH receptor antibody, or TRAb. Graves’ disease is the most common cause of hyperthyroidism in areas of sufficient iodine intake. About 25–50% of Graves’ disease patients show clinically obvious Graves’ ophthalmopathy or thyroid eye disease (inflammation and bulging of the eyes).2 Only 8% of these patients will have severe thyroid eye disease.3 

Who is at risk?

Women are eight times more likely to develop Graves’ disease than men. This disorder commonly affects women between 40‒60 years.4

Smoking increases the risk of developing Graves’ disease by two-fold.4 Smokers who have Graves’ disease are also more prone to severe thyroid eye disease.3 

Symptoms of Graves’ disease

This disease can go unnoticed for a long time, but you may experience some of the following symptoms due to high thyroid hormone levels:1,5

  • Fast heart rate
  • Nervousness and/or irritability
  • Anxiety
  • Difficulty sleeping
  • Weight loss without dietary change
  • Muscle weakness, especially of the upper arms and thighs
  • Increased sweating
  • Frequent bowel movements
  • Lighter or less frequent menstrual periods
  • Trembling hands
  • Thinning of the skin

  • Fine brittle hair

Symptoms of thyroid eye disease include:3 

  • Bulging eyes
  • Eye redness and pain
  • Lid swelling
  • Double vision

Diagnosing Graves’ disease

Symptoms alone are not a reliable proof of this disease. A blood test known as. thyroid function test to check the level of thyroid-stimulating hormone (TSH) and thyroid hormones in your blood is needed to make a valid diagnosis. If you have low levels of TSH in the blood and high levels of thyroid hormones, you have hyperthyroidism. Measurement of TSH receptor antibodies (TRAb) confirms the diagnosis of Graves’ disease.6

Treatment of Graves' disease

The goals of treatment for Graves' disease are to stop the production of thyroid hormones and to block the effect of the hormones on the body. The treatment options include anti thyroid medications, radioactive iodine, or thyroid surgery.7 Discuss with your doctor about which treatment option is best suited for your condition.

Summary

  • Graves’ disease, an autoimmune thyroid condition, is the most common cause of hyperthyroidism
  • Diagnosis of Graves’ disease is confirmed via blood tests that checks thyroid function and the presence of TSH receptor antibodies (TRAb) 
  • Treatment options of Graves’ disease include anti thyroid medications, radioiodine treatment or thyroid surgery.

References

  1. American Thyroid Association. Graves’ disease. 2017. Available at: https://www.thyroid.org/wp-content/uploads/patients/brochures/Graves_brochure.pdf. Last accessed June 2023. 
  2. Goh SY, Ho SC, Seah LL, et al. Thyroid autoantibody profiles in ophthalmic dominant and thyroid dominant Graves’ disease differ and suggest ophthalmopathy is a multiantigenic disease. Clin Endocrinol. 2004; 60: 600-7.
  3. Lim NCS, Sundar G, Amrith S, et al. Thyroid eye disease: a Southeast Asian experience. Br J Ophthalmol. 2014; 0: 1-7.
  4. Yeo JLS, Yong NTWM, Mahendran DCJ, et al. Approach to goitre in family medicine. Singapore Med J. 2022; 63: 604-14.
  5. American Thyroid Association. Hyperthyroidism. 2018. Available at: https://www.thyroid.org/wp-content/uploads/patients/brochures/Hyper_brochure.pdf. Last accessed June 2023.
  6. Ginsberg J. Diagnosis and management of Graves’ disease. CMAJ 2003; 168: 575-85
  7. Chng CL. Graves’ disease. In: Parameswaran R, Agarwal A (eds). Evidence-based endocrine surgery. Singapore; Springer: 2018. Available at: https://doi.org/10.1007/978-981-10-1124-5. Last accessed 22 August 2023.
SG-NONT-00025 | December 2023